Voloridge Investment Management LLC Takes $396,000 Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Voloridge Investment Management LLC purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 30,156 shares of the company's stock, valued at approximately $396,000.

Other large investors have also recently bought and sold shares of the company. XTX Topco Ltd bought a new stake in Pediatrix Medical Group during the 4th quarter worth $169,000. SG Americas Securities LLC bought a new position in shares of Pediatrix Medical Group during the 4th quarter worth about $171,000. Principal Financial Group Inc. increased its position in Pediatrix Medical Group by 7.5% in the 4th quarter. Principal Financial Group Inc. now owns 551,924 shares of the company's stock valued at $7,241,000 after buying an additional 38,306 shares in the last quarter. Deutsche Bank AG grew its position in Pediatrix Medical Group by 53.1% in the 4th quarter. Deutsche Bank AG now owns 74,023 shares of the company's stock valued at $971,000 after purchasing an additional 25,663 shares during the period. Finally, Smartleaf Asset Management LLC increased its stake in Pediatrix Medical Group by 750.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after purchasing an additional 6,090 shares in the last quarter. 97.71% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Macquarie increased their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. UBS Group reduced their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research report on Monday, May 12th. Finally, Truist Financial reduced their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, Pediatrix Medical Group presently has an average rating of "Hold" and an average price target of $16.67.

Pediatrix Medical Group Price Performance

Shares of MD stock traded up $0.31 during trading hours on Tuesday, hitting $13.85. 767,076 shares of the company's stock were exchanged, compared to its average volume of 850,534. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67. The business's 50 day simple moving average is $13.67 and its 200-day simple moving average is $14.02. The company has a market capitalization of $1.19 billion, a PE ratio of -11.54, a PEG ratio of 1.74 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.08. The firm had revenue of $458.36 million for the quarter, compared to analysts' expectations of $451.44 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company's revenue for the quarter was down 7.4% compared to the same quarter last year. During the same period last year, the firm earned $0.20 earnings per share. On average, equities research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.